Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,610 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $508.02 | 9 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $299.03 | 5 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $187.17 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $165.33 | 7 | $0 (2023) |
| Merck Sharp & Dohme LLC | $100.21 | 1 | $0 (2023) |
| CSL Behring | $97.76 | 1 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $92.71 | 2 | $0 (2021) |
| La Jolla Pharmaceutical Company | $78.56 | 1 | $0 (2020) |
| ABBVIE INC. | $68.36 | 3 | $0 (2022) |
| Inari Medical, Inc. | $12.91 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.84 | 1 | AstraZeneca Pharmaceuticals LP ($22.84) |
| 2023 | $321.14 | 9 | Merck Sharp & Dohme LLC ($100.21) |
| 2022 | $728.32 | 11 | AstraZeneca Pharmaceuticals LP ($329.92) |
| 2021 | $269.72 | 7 | Alexion Pharmaceuticals, Inc. ($133.93) |
| 2020 | $162.10 | 6 | La Jolla Pharmaceutical Company ($78.56) |
| 2019 | $105.94 | 1 | AstraZeneca Pharmaceuticals LP ($105.94) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Rare Disease | ||||||
| 10/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Cardiovascular | ||||||
| 05/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $97.76 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 04/06/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: VTE | ||||||
| 01/20/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: Cardiovascular | ||||||
| 01/12/2023 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $100.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $109.55 | General |
| Category: Rare Disease | ||||||
| 10/13/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $97.91 | General |
| Category: Rare Disease | ||||||
| 10/11/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/28/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Rare Disease | ||||||
| 09/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $55.92 | General |
| Category: Cardiovascular | ||||||
| 08/06/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Rare Disease | ||||||
| 07/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $109.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/07/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $112.18 | General |
| Category: Rare Disease | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $80.05 | General |
| Category: Gastroenterology | ||||||
| 10/16/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Hematology | ||||||
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Gastroenterology | ||||||
| 07/08/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $108.23 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 441 | 449 | $439,151 | $39,667 |
| 2022 | 5 | 215 | 223 | $151,406 | $15,835 |
| 2021 | 3 | 77 | 78 | $48,129 | $6,258 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 216 | 222 | $327,162 | $30,070 | 9.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 88 | 88 | $89,696 | $7,817 | 8.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 22 | 22 | $12,997 | $1,060 | 8.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 115 | 117 | $9,296 | $721.05 | 7.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 65 | 67 | $90,827 | $9,160 | 10.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 38 | 40 | $34,579 | $3,815 | 11.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 40 | 40 | $19,051 | $2,128 | 11.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 61 | 65 | $4,463 | $407.70 | 9.1% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 11 | 11 | $2,486 | $324.36 | 13.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 15 | 15 | $13,612 | $2,260 | 16.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 40 | 41 | $18,202 | $2,180 | 12.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 22 | 22 | $16,316 | $1,818 | 11.1% |
About Dr. Ryan Griswold, DO
Dr. Ryan Griswold, DO is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2019. The National Provider Identifier (NPI) number assigned to this provider is 1710541297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Griswold, DO has received a total of $1,610 in payments from pharmaceutical and medical device companies, with $22.84 received in 2024. These payments were reported across 35 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,610).
As a Medicare-enrolled provider, Griswold has provided services to 733 Medicare beneficiaries, totaling 750 services with total Medicare billing of $61,760. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 04/30/2019
- Last Updated 01/26/2022
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1710541297
Products in Payments
- ANDEXXA (Biological) $311.76
- LOKELMA (Drug) $263.45
- XARELTO (Drug) $187.17
- ELIQUIS (Drug) $165.33
- Andexxa (Drug) $133.93
- RECARBRIO (Drug) $100.21
- ULTOMIRIS (Biological) $97.91
- Kcentra (Biological) $97.76
- RELISTOR (Drug) $92.71
- GIAPREZA (Drug) $78.56
- DALVANCE (Drug) $68.36
- FLOWTRIEVER CATHETER, S (Device) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117